Hepatitis B: SAMBA Study on Antibodies

We are investigating the safety and effects of new antibodies for people with hepatitis B. This study aims to learn more about how these treatments may help manage the disease.

Safety phase (I)HepatologyInfectious Diseases

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Aalborg University Hospital
Dept. of Infectious Diseases
Aalborg, Denmark
Region Midtjylland
Dept. of Infectious Diseases
Århus, Denmark
Rigshospitalet
Dept. of Infectious Diseases
Copenhagen, Denmark

Sponsor: Region Midtjylland
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.